SecureKloud Tech

Q2 FY21 Earnings Call Analysis

IT - Services

Full Stock Analysis
fundraise: Yescapex: Yesrevenue: Category 3margin: Category 2orderbook: Yes
πŸ’°

fundraise

Any current/future new fundraising through debt or equity?

- The board approved a capital raising plan of approximately Rs.150 Crores (around USD 20 million) for Blockedge Technologies Inc., a 100% subsidiary of SecureKloud, to be presented for shareholder approval at the AGM on September 30, 2021. - The subsidiary fundraise is planned as equity investment (capital raising). - Regarding Healthcare Triangle’s NASDAQ listing, the company is anticipating raising around USD 25 million, but the exact dilution or pricing is not yet determined as it awaits SEC clearance. - SecureKloud aims to keep dilution low by raising around USD 25 million in funds but has capacity to raise more if needed. - No specific mention of new debt fundraising was made in the call. - Overall, current focus is on equity fundraising for growth initiatives particularly for Blockedge and Healthcare Triangle's listing.
πŸ—οΈ

capex

Any current/future capex/capital investment/strategic investment?

- The board approved a capital raising plan of approximately Rs.150 Crores (USD 20 million) for Blockedge Technologies Inc., a 100% US-based subsidiary of SecureKloud. - The approval was given on the day of the call (August 6, 2021), with shareholder approval planned for the AGM on September 30, 2021. - The funds raised will be used to support sales and marketing efforts specific to the Blockedge platform. - SecureKloud is continuing to invest in sales and marketing, including hiring new sales personnel to drive growth. - Investments in product development and enhancements continue for platform-based services such as DRaaS, CloudEz, and DataEz. - The company focuses on building a platform-as-a-service business model with recurring revenue streams.
πŸ“Š

revenue

Future growth expectations in sales/revenue/volumes?

- Revenue growth expected in the next two quarters as the company witnesses shift from one-time revenue to recurring revenue model. - Addition of new sales force and investment in sales & marketing to speed up customer acquisition. - Growth potential in Blockedge blockchain platform with dedicated sales team planned, aiming to increase revenue substantially. - Expansion into new verticals such as pharma, automotive, insurance, land registry, and government sectors. - Geographic expansion in Europe, Middle East, Japan, UK, India, US, and other markets. - Multiyear contracts and recurring revenues from existing and new clients enhancing revenue visibility. - Collaboration with consortiums in pharma and automotive to broaden customer base. - Anticipated steady growth in recurring revenues, currently at 36.9%, led by Life Sciences and Healthcare sectors. - Focus on platform-as-a-service business model for higher enterprise value.
πŸ“ˆ

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Revenue growth is expected in the next few quarters due to increased sales efforts and a healthy sales pipeline, especially with new client acquisitions and expansion in various geographies including Europe, Middle East, Japan, UK, and India. - Transition from one-time revenue to recurring revenue models (SaaS/platform as a service) is anticipated to support sustainable growth and improve margins. - Gross margins were impacted by higher low-margin revenue share, subcontracting costs, and salary revisions, but operational improvements like automation and productivity enhancements are planned to offset these. - Investment in sales and marketing has been substantial; benefits of this will reflect in revenue growth and margins in coming quarters. - Focus on platform-based services such as CloudEz, DataEz, and Blockedge, with potential in pharma, automotive, and government sectors, is expected to drive high-value enterprise growth. - Profits should improve sequentially as revenue grows and operational efficiencies increase.
πŸ“‹

orderbook

Current/ Expected Orderbook/ Pending Orders?

- SecureKloud has a strong order backlog in Life Sciences and Healthcare verticals. - New logos acquired in the last two quarters, including seven new logos in the current quarter from India and the US. - Expansion plans in Europe, Middle East, and Japan aimed at reducing dependency on large customers. - Healthy sales pipeline with promising traction in new client opportunities. - Top five to ten customers contribute the majority of revenue. - Expect revenue uptick to start reflecting in the next couple of quarters. - Multiyear agreements being discussed with customers in healthcare for implementation, support services, and Disaster Recovery as a Service (DRaaS). - Some past customers have returned due to positive engagement and service quality.